17.17 USD
+0.09
0.53%
At close Updated Sep 17, 4:00 PM EDT
Pre-market
After hours
17.34
+0.17
0.99%
1 day
0.53%
5 days
5.08%
1 month
14.85%
3 months
59.87%
6 months
17.6%
Year to date
2.75%
1 year
-7.09%
5 years
-23.11%
10 years
81.69%
 

About: The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Employees: 6,000

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

71% more repeat investments, than reductions

Existing positions increased: 156 | Existing positions reduced: 91

67% more funds holding in top 10

Funds holding in top 10: 3 [Q1] → 5 (+2) [Q2]

39% more call options, than puts

Call options by funds: $25.1M | Put options by funds: $18.1M

38% more first-time investments, than exits

New positions opened: 80 | Existing positions closed: 58

7.57% more ownership

Funds ownership: 92.35% [Q1] → 99.92% (+7.57%) [Q2]

4% more funds holding

Funds holding: 414 [Q1] → 430 (+16) [Q2]

8% less capital invested

Capital invested by funds: $1.87B [Q1] → $1.71B (-$154M) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$15
13% downside
Avg. target
$17.33
1% upside
High target
$21
22% upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Truist Securities
Peter Osterland
$21
Buy
Maintained
16 Sep 2025
Mizuho
John Roberts
$16
Outperform
Maintained
15 Jul 2025
RBC Capital
Arun Viswanathan
$15
Outperform
Maintained
3 Jul 2025

Financial journalist opinion

Based on 4 articles about CC published over the past 30 days

Neutral
Business Wire
14 days ago
Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director
WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) today announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act. “While.
Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director
Neutral
Business Wire
22 days ago
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals.
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
Positive
Zacks Investment Research
28 days ago
Chemours Enters Strategic Agreement With SRF to Boost Supply
CC partners with SRF to expand global supply chain, boost operational flexibility and strengthen its high-value product mix.
Chemours Enters Strategic Agreement With SRF to Boost Supply
Neutral
Business Wire
29 days ago
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026.
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
Neutral
Business Wire
1 month ago
Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid.
Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
Positive
Zacks Investment Research
1 month ago
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
CC posts Q2 earnings and sales beat driven by volume and pricing gains, but issues softer sequential guidance.
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
Positive
Seeking Alpha
1 month ago
Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)
Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey PFAS settlement, freeing up future cash flow and reducing uncertainty. Balance sheet leverage remains high, but improving free cash flow in the second half should reduce net debt and support the current dividend.
Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)
Positive
The Motley Fool
1 month ago
Chemours (CC) Q2 EPS Jumps 53%
Chemours (CC) Q2 EPS Jumps 53%
Chemours (CC) Q2 EPS Jumps 53%
Neutral
Seeking Alpha
1 month ago
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
The Chemours Company (NYSE:CC ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise M. Dignam - President, CEO & Director Shane W.
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say
Charts implemented using Lightweight Charts™